Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guizhi Gancao Decoction is a classic Traditional Chinese Medicine (TCM) and Kampo formula consisting of two primary herbs: Cinnamomi Ramulus (Guizhi) and Glycyrrhizae Radix et Rhizoma (Gancao). Traditionally used to treat heart-yang deficiency characterized by palpitations and restlessness, it is currently being evaluated for its potential in managing post-COVID-19 syndrome symptoms, including fatigue, memory impairment, and sleep disturbances. The formula is thought to exert anti-inflammatory and neuroprotective effects, potentially modulating the autonomic nervous system and inflammatory cytokines through active constituents like cinnamaldehyde and glycyrrhizin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on guizhi gancao decoction.